← All Investors
INNATE PHARMA S A
IPHA
Holders
1
Combined Value
$12K
Combined Shares
10,064
Current Price
$1.78
52W High
$2.63
vs 52W High
−32.3%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Israel Englander - Millennium Management | $12K | 0.00% | ~$1.75 | +1.7% | Sold Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Israel Englander - Millennium Management | SELL | −$13K | ~$1.28 |
| Q4 2025 | Israel Englander - Millennium Management | NEW BUY | +$35K | ~$1.75 |
| Q4 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$39K | ~$1.95 |
| Q3 2025 | Israel Englander - Millennium Management | SOLD OUT | −$20K | ~$1.75 |
| Q3 2025 | Ken Griffin - Citadel Advisors | SELL | −$12K | ~$1.95 |
| Q2 2025 | Israel Englander - Millennium Management | SELL | −$6K | ~$1.75 |
| Q2 2025 | Ken Griffin - Citadel Advisors | BUY | +$4K | ~$1.75 |
| Q1 2025 | Israel Englander - Millennium Management | NEW BUY | +$27K | ~$1.78 |
| Q1 2025 | Ken Griffin - Citadel Advisors | BUY | +$22K | ~$1.78 |
| Q4 2024 | Ken Griffin - Citadel Advisors | SELL | −$17K | ~$1.85 |
| Q3 2024 | Ken Griffin - Citadel Advisors | SELL | −$5K | ~$2.29 |
| Q2 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$45K | ~$1.94 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 1 | 10,064 | −50.4% | $12K | $1.28 |
| Q4 2025 | 1 | 20,308 | +1.3% | $35K | $1.75 |
| Q3 2025 | 1 | 20,042 | −47.6% | $39K | $1.95 |
| Q2 2025 | 2 | 38,278 | −3.3% | $66K | $1.75 |
| Q1 2025 | 2 | 39,593 | +234.0% | $70K | $1.78 |
| Q4 2024 | 1 | 11,853 | −44.3% | $21K | $1.85 |
| Q3 2024 | 1 | 21,267 | −9.6% | $48K | $2.29 |
| Q2 2024 | 1 | 23,527 | — | $45K | $1.94 |